Better by design: the role of delivery device design in biosimilar adoption

Manufacturing Chemist shares developments across all the areas of the pharma supply chain as well as comprehensive technical articles, market analysis and insights of those who are shaping the industry. It covers international industry news and features in-depth articles on key topics making it an integral read for those working in or around the global pharmaceutical marketplace.

In the April 2020 edition of Manufacturing Chemist, George I’ons, Head of Product Strategy at Owen Mumford Pharmaceutical Services analyses the different factors that will influence the takeup of new biosimilars and their advancing market share against original biologics. The article also focuses on clinical confidence in biosimilars and the increasingly aggressive pricing of drugs as a result of greater competition.